BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20681793)

  • 1. Impact of RING and BRCT domain mutations on BRCA1 protein stability, localization and recruitment to DNA damage.
    Nelson AC; Holt JT
    Radiat Res; 2010 Jul; 174(1):1-13. PubMed ID: 20681793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BRCA1 RING and BRCT domains cooperate in targeting BRCA1 to ionizing radiation-induced nuclear foci.
    Au WW; Henderson BR
    J Biol Chem; 2005 Feb; 280(8):6993-7001. PubMed ID: 15569676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural requirements for the BARD1 tumor suppressor in chromosomal stability and homology-directed DNA repair.
    Laufer M; Nandula SV; Modi AP; Wang S; Jasin M; Murty VV; Ludwig T; Baer R
    J Biol Chem; 2007 Nov; 282(47):34325-33. PubMed ID: 17848578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of sequences that target BRCA1 to nuclear foci following alkylative DNA damage.
    Au WW; Henderson BR
    Cell Signal; 2007 Sep; 19(9):1879-92. PubMed ID: 17531442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of BRCA1 protein targeting, dynamics, and function at the centrosome: a role for the nuclear export signal, CRM1, and Aurora A kinase.
    Brodie KM; Henderson BR
    J Biol Chem; 2012 Mar; 287(10):7701-16. PubMed ID: 22262852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export.
    Fabbro M; Rodriguez JA; Baer R; Henderson BR
    J Biol Chem; 2002 Jun; 277(24):21315-24. PubMed ID: 11925436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytoplasmic mislocalization of BRCA1 caused by cancer-associated mutations in the BRCT domain.
    Rodriguez JA; Au WW; Henderson BR
    Exp Cell Res; 2004 Feb; 293(1):14-21. PubMed ID: 14729053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HP1 regulates the localization of FANCJ at sites of DNA double-strand breaks.
    Wu W; Togashi Y; Johmura Y; Miyoshi Y; Nobuoka S; Nakanishi M; Ohta T
    Cancer Sci; 2016 Oct; 107(10):1406-1415. PubMed ID: 27399284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of BARD1 targeting and dynamics at the centrosome: the role of CRM1, BRCA1 and the Q564H mutation.
    Brodie KM; Mok MTS; Henderson BR
    Cell Signal; 2012 Feb; 24(2):451-459. PubMed ID: 21982881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
    Rodriguez M; Yu X; Chen J; Songyang Z
    J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the BRCT binding site of BRCA1 result in hyper-recombination.
    Dever SM; Golding SE; Rosenberg E; Adams BR; Idowu MO; Quillin JM; Valerie N; Xu B; Povirk LF; Valerie K
    Aging (Albany NY); 2011 May; 3(5):515-32. PubMed ID: 21666281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 recruitment to damaged DNA sites is dependent on CDK9.
    Nepomuceno TC; Fernandes VC; Gomes TT; Carvalho RS; Suarez-Kurtz G; Monteiro AN; Carvalho MA
    Cell Cycle; 2017 Apr; 16(7):665-672. PubMed ID: 28278048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRCA1 promotes induction of ssDNA by ionizing radiation.
    Schlegel BP; Jodelka FM; Nunez R
    Cancer Res; 2006 May; 66(10):5181-9. PubMed ID: 16707442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites.
    Wu Q; Paul A; Su D; Mehmood S; Foo TK; Ochi T; Bunting EL; Xia B; Robinson CV; Wang B; Blundell TL
    Mol Cell; 2016 Feb; 61(3):434-448. PubMed ID: 26778126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for cell cycle checkpoint control by the BRCA1-CtIP complex.
    Varma AK; Brown RS; Birrane G; Ladias JA
    Biochemistry; 2005 Aug; 44(33):10941-6. PubMed ID: 16101277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention.
    Fabbro M; Schuechner S; Au WW; Henderson BR
    Exp Cell Res; 2004 Aug; 298(2):661-73. PubMed ID: 15265711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BACH1 is a DNA repair protein supporting BRCA1 damage response.
    Peng M; Litman R; Jin Z; Fong G; Cantor SB
    Oncogene; 2006 Apr; 25(15):2245-53. PubMed ID: 16462773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of cancer related BRCA1 missense variants decreases MMS-induced recombination in Saccharomyces cerevisiae without altering its nuclear localization.
    Lodovichi S; Vitello M; Cervelli T; Galli A
    Cell Cycle; 2016 Oct; 15(20):2723-31. PubMed ID: 27484786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of
    Petitalot A; Dardillac E; Jacquet E; Nhiri N; Guirouilh-Barbat J; Julien P; Bouazzaoui I; Bonte D; Feunteun J; Schnell JA; Lafitte P; Aude JC; Noguès C; Rouleau E; Lidereau R; Lopez BS; Zinn-Justin S; Caputo SM;
    Mol Cancer Res; 2019 Jan; 17(1):54-69. PubMed ID: 30257991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.